Action of radiation or alkylating agents on LSA lymphoma during growth.
D000477:Alkylating Agents / Q000627:therapeutic use*; D000818:Animals; D002330:Carmustine / Q000627:therapeutic use; D002470:Cell Survival; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D007700:Kinetics; D008223:Lymphoma / Q000628:therapy*; D008466:Mechlorethamine / Q000627:therapeutic use; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000628:therapy; D011882:Radiotherapy, High-Energy
D000477:Alkylating Agents; D003037:Cobalt Radioisotopes; D008466:Mechlorethamine; D003520:Cyclophosphamide; D002330:Carmustine